(Q45121876)

9 December 2017

title

Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation (English)

1 reference

9 December 2017

8

Wolfgang C Winkelmayer

1 reference

9 December 2017

Waichi Wong

1

1 reference

9 December 2017

Neerja Agrawal

2

1 reference

9 December 2017

Manuel Pascual

3

1 reference

9 December 2017

David C Anderson

4

1 reference

9 December 2017

Hans H Hirsch

5

1 reference

9 December 2017

Kumiko Fujimoto

6

1 reference

9 December 2017

Francesca Cardarelli

7

1 reference

9 December 2017

A Benedict Cosimi

9

1 reference

9 December 2017

Nina Tolkoff-Rubin

10

1 reference

9 December 2017

publication date

1 August 2006

1 reference

9 December 2017

published in

Transplant International

1 reference

9 December 2017

volume

19

1 reference

9 December 2017

issue

8

1 reference

9 December 2017

page(s)

629-635

1 reference

Immunosuppression: evolution in practice and trends, 1993-2003.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

ATG induction therapy: long-term effects on Th1 but not on Th2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

BK virus nephropathy--polyomavirus adding insult to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00270.X

10.1111/J.1432-2277.2006.00270.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference